Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 37488293.
- Also identified by DOI 10.1038/s41591-023-02464-8 and PMC identifier 11983287.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A breakthrough in drug discovery for glioblastoma requires serial collection of tissue from the central nervous system via window of opportunity trials
Medical subject headings
- Glioblastoma
- Brain Neoplasms